Position in MRNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$21,652,995
+$9,927,136 QoQ
Shares Held
309,196
+34.0% QoQ
Ownership
0.077%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#71
of 777 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Sep 30, 2020CallValue
$27,071,000
CallShares
38,214,700
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. MRNA ranks #34 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
195,674 | $122,010,565 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
556,392 | $104,201,093 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
199,505 | $99,100,118 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
314,512 | $94,677,547 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
289,735 | $82,565,782 | |
| 6 | COGT |
Cogent Biosciences, Inc.
|
2,088,369 | $80,819,880 | |
| 7 | ARGX |
Argenx SE
|
80,120 | $74,332,932 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
1,990,510 | $70,444,148 |
All Filings in MRNA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $21,652,995 | 309,196 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $11,725,859 | 230,824 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $6,753,151 | 228,998 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $5,620,711 | 217,604 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $6,097,003 | 220,986 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $7,993,168 | 281,946 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $25,482,801 | 612,862 | Shares | Other | 2025-02-07 | |
| 2024-09-30 | $41,946,918 | 627,666 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $57,243,675 | 482,052 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $47,104,315 | 442,045 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $36,104,725 | 363,044 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $45,691,364 | 442,360 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $42,541,888 | 350,139 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $62,690,434 | 408,194 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $75,463,211 | 420,127 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $29,077,556 | 245,899 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $19,352,460 | 135,474 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $22,436,865 | 130,250 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $42,989,670 | 169,264 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $80,264,477 | 208,555 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $72,142,149 | 307,014 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $51,878,068 | 396,167 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $41,387,566 | 396,167 | Shares | Sole | 2021-01-22 | |
| 2020-09-30 | $27,071,000 | 38,214,700 | Call | Sole | 2020-10-19 | |
| 2020-06-30 | $18,353,401 | 285,834 | Shares | Sole | 2020-07-23 | |
| No filing history on record for this holder in this stock. | ||||||